American Association for Cancer Research Forum addresses racism and inequality in cancer trials A forum at the American Association for Cancer Research (AACR) addressed the issue of racism and inequality in research. The forum at AACR’s Virtual Annual Meeting II featured several racially and ethnically diverse leaders in the oncology community and focused on the underrepresentation of people of color in clinical trials, academic training programs and leadership
Risk Based Monitoring- a data-centric approach to monitoring The outbreak and spread of the COVID-19 (SARS-CoV-2) pandemic continues to have a significant negative impact on the clinical trials industry. Restrictions to curb the spread of the virus caused many sites to be temporarily closed to external visits and resulted in postponements and delays to trials. In spite of these challenges, the industry has
EU Clinical Trials Information System set to go live end of 2021 The EU’s Clinical Trials Information System (CTIS), a centralized portal and database for information storage foreseen by the Clinical Trials Regulation (2014), is set to go live in December 2021. The go live date was confirmed at the most recent virtual meeting of the Board of the European Medicines Agency (EMA) (11 June, 2020). In
